Orion is a globally operating pharmaceutical company based in Finland. They specialize in developing, manufacturing, and marketing human and veterinary pharmaceuticals and active pharmaceutical ingredients. With a focus on oncology and pain, Orion continuously works on creating new drugs and treatment methods. In 2021, their net sales reached EUR 1,041 million, and they employed approximately 3,350 people. Orion's A and B shares are listed on Nasdaq Helsinki. They serve a wide range of customers, including specialists, general practitioners, veterinarians, pharmacies, hospitals, and laboratories. While their main market is Finland, Orion also has a presence in other European countries and North America.